Literature DB >> 34595609

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive-Compulsive Disorder.

Sankalp Tikoo1, Antonio Suppa1,2, Silvia Tommasin1,3, Costanza Giannì2, Giulia Conte1, Giovanni Mirabella4,2, Francesco Cardona1, Patrizia Pantano5,6.   

Abstract

Tourette syndrome (TS) and obsessive-compulsive disorder (OCD) are two neurodevelopmental disorders characterized by repetitive behaviors. Our recent study in drug-naive children with TS and OCD provided evidence of cerebellar involvement in both disorders. In addition, cerebellar functional connectivity (FC) was similar in TS patients without comorbidities (TSpure) and TS patients with OCD comorbidity (TS + OCD), but differed in pure OCD patients. To investigate in detail the cerebellar involvement in the pathophysiology of TS and OCD, we explored cerebellar structural and functional abnormalities in drug-naive children with TSpure, TS + OCD, and OCD and assessed possible correlations with severity scores. We examined 53 drug-naive children, classified as TSpure (n = 16), TS + OCD (n = 14), OCD (n = 11), or controls (n = 12). All subjects underwent a multimodal 3T magnetic resonance imaging examination. Cerebellar lobular volumes and quantitative diffusion tensor imaging parameters of cerebellar peduncles were used as measures of structural integrity. The dentate nucleus was selected as a region of interest to examine cerebello-cerebral functional connectivity alterations. Structural analysis revealed that both TSpure and TS + OCD patients had higher fractional anisotropy in cerebellar peduncles than controls. Conversely, OCD patients were characterized by lower fractional anisotropy than both controls and TSpure and TS + OCD patients. Lastly, cerebellar functional connectivity analysis revealed significant alterations in the cerebello-thalamo-cortical circuit in TSpure, TS + OCD, and OCD patients. Early cerebellar structural and functional changes in drug-naive pediatric TSpure, TS + OCD, and OCD patients support a primary role of the cerebellum in the pathophysiology of these disorders.
© 2021. The Author(s).

Entities:  

Keywords:  Cerebellum; Obsessive–compulsive disorder; Structural connectivity and functional connectivity, Drug-naive children; Tourette syndrome

Year:  2021        PMID: 34595609     DOI: 10.1007/s12311-021-01327-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  43 in total

Review 1.  Toward a neurobiology of obsessive-compulsive disorder.

Authors:  A M Graybiel; S L Rauch
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder.

Authors:  E C Miguel; M C do Rosário-Campos; H S Prado; R do Valle; S L Rauch; B J Coffey; L Baer; C R Savage; R L O'Sullivan; M A Jenike; J F Leckman
Journal:  J Clin Psychiatry       Date:  2000-02       Impact factor: 4.384

Review 3.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

4.  Neurological Soft Signs and Clinical Features of Tic-Related Obsessive-Compulsive Disorder Indicate a Unique Subtype.

Authors:  Okan Ekinci; Asli Erkan Ekinci
Journal:  J Nerv Ment Dis       Date:  2020-01       Impact factor: 2.254

Review 5.  Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder.

Authors:  Andrea E Cavanna
Journal:  CNS Spectr       Date:  2018-05-21       Impact factor: 3.790

6.  Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?

Authors:  D C Cath; P Spinhoven; T C van Woerkom; B J van de Wetering; C A Hoogduin; A D Landman; R A Roos; H G Rooijmans
Journal:  J Nerv Ment Dis       Date:  2001-04       Impact factor: 2.254

7.  Alterations in cerebellar grey matter structure and covariance networks in young people with Tourette syndrome.

Authors:  Hilmar P Sigurdsson; Stephen R Jackson; Laura Jolley; Ellie Mitchell; Georgina M Jackson
Journal:  Cortex       Date:  2020-01-22       Impact factor: 4.027

8.  Systematic review of co-occurring OCD and TD: Evidence for a tic-related OCD subtype?

Authors:  Lisa Kloft; Theresa Steinel; Norbert Kathmann
Journal:  Neurosci Biobehav Rev       Date:  2018-09-29       Impact factor: 8.989

9.  Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?

Authors:  Yulia Worbe; Luc Mallet; Jean-Louis Golmard; Cécile Béhar; Franck Durif; Isabelle Jalenques; Philippe Damier; Pascal Derkinderen; Pierre Pollak; Mathieu Anheim; Emannuel Broussolle; Jing Xie; Valérie Mesnage; Karl Mondon; François Viallet; Pierre Jedynak; Mouna Ben Djebara; Michael Schüpbach; Antoine Pelissolo; Marie Vidailhet; Yves Agid; Jean-Luc Houeto; Andreas Hartmann
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

10.  Resting-state functional connectivity in drug-naive pediatric patients with Tourette syndrome and obsessive-compulsive disorder.

Authors:  Sankalp Tikoo; Francesco Cardona; Silvia Tommasin; Costanza Giannì; Giulia Conte; Neeraj Upadhyay; Giovanni Mirabella; Antonio Suppa; Patrizia Pantano
Journal:  J Psychiatr Res       Date:  2020-07-07       Impact factor: 4.791

View more
  2 in total

1.  Changing life styles for children with Tourette syndrome.

Authors:  Huei-Shyong Wang
Journal:  Biomed J       Date:  2022-03-14       Impact factor: 7.892

2.  White matter alterations in drug-naïve children with Tourette syndrome and obsessive-compulsive disorder.

Authors:  Komal Bharti; Giulia Conte; Silvia Tommasin; Costanza Giannì; Antonio Suppa; Giovanni Mirabella; Francesco Cardona; Patrizia Pantano
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.